Literature DB >> 22089249

Influence of dietary sodium modulation on electrocardiographic voltage criteria for left ventricular hypertrophy in normotensive individuals.

Carol Larson1, Anand Vaidya, Bei Sun, Jonathan S Williams.   

Abstract

OBJECTIVE: Dietary sodium intake and left ventricular hypertrophy (LVH) on electrocardiogram (ECG) are both independent determinants of cardiovascular risk. Prior studies demonstrated that acute dietary sodium modulation significantly altered LVH-specific ECG voltage in hypertensive individuals, thus modifying cardiovascular risk prediction; but whether this phenomenon exists in normotensive individuals is not known. We evaluated the influence of dietary sodium intake on ECG voltage and ECG criteria for LVH in normotensive individuals.
METHODS: Retrospective evaluation of ECGs of healthy normotensive individuals (n = 39) who were prospectively randomized to a dietary study protocol of 1 week of high-sodium diet (>200 mmol of sodium per day) and 1 week of low-sodium diet (<10 mmol/d) was conducted. Electrocardiogram voltage amplitudes and biochemical assessments were performed at the end of each dietary intervention.
RESULTS: As expected, blood pressure declined and measures of circulating renin-angiotensin-aldosterone system activity rose significantly with low-sodium diet. No significant changes in specific LVH voltage criteria or overall precordial or limb lead ECG voltage amplitudes were detected between diets.
CONCLUSION: Although immediate dietary sodium modulation has been shown to significantly alter LVH-specific ECG voltage and the detection of LVH in hypertensive individuals, dietary sodium intake did not influence ECG voltage in normotensive individuals. Healthy normotensive individuals may exhibit adaptive measures that dampen ECG voltage fluctuations in response to dietary sodium modulation. More specific cardiac imaging studies may provide additional insight into this observation and the influence of dietary sodium in cardiac health.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22089249      PMCID: PMC3246128          DOI: 10.2310/JIM.0b013e31823d05ab

Source DB:  PubMed          Journal:  J Investig Med        ISSN: 1081-5589            Impact factor:   2.895


  23 in total

1.  Physiologic determinants of the electrocardiographic diagnosis of left ventricular hypertrophy.

Authors:  E M Antman; L H Green; W Grossman
Journal:  Circulation       Date:  1979-08       Impact factor: 29.690

2.  Reducing the population burden of cardiovascular disease by reducing sodium intake: a report of the Council on Science and Public Health.

Authors:  Barry D Dickinson; Stephen Havas
Journal:  Arch Intern Med       Date:  2007-07-23

3.  Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.

Authors:  Dimitris Tsiachris; Christina Chrysohoou; Evagelos Oikonomou; George Lazaros; Kyriakos Dimitriadis; Dimitris Maragiannis; Dimitris Roussos; Ioannis Andreou; Apostolos Tsantilas; Evagelia Christoforatou; Christos Pitsavos; Demosthenes Panagiotakos; Christodoulos Stefanadis
Journal:  J Hypertens       Date:  2011-08       Impact factor: 4.844

4.  Left ventricular hypertrophy by electrocardiogram. Prevalence, incidence, and mortality in the Framingham study.

Authors:  W B Kannel; T Gordon; D Offutt
Journal:  Ann Intern Med       Date:  1969-07       Impact factor: 25.391

5.  Premature mortality from coronary heart disease. The Framingham study.

Authors:  T Gordon; W B Kannel
Journal:  JAMA       Date:  1971-03-08       Impact factor: 56.272

6.  Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group.

Authors:  F M Sacks; L P Svetkey; W M Vollmer; L J Appel; G A Bray; D Harsha; E Obarzanek; P R Conlin; E R Miller; D G Simons-Morton; N Karanja; P H Lin
Journal:  N Engl J Med       Date:  2001-01-04       Impact factor: 91.245

7.  Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

Authors:  Björn Dahlöf; Richard B Devereux; Sverre E Kjeldsen; Stevo Julius; Gareth Beevers; Ulf de Faire; Frej Fyhrquist; Hans Ibsen; Krister Kristiansson; Ole Lederballe-Pedersen; Lars H Lindholm; Markku S Nieminen; Per Omvik; Suzanne Oparil; Hans Wedel
Journal:  Lancet       Date:  2002-03-23       Impact factor: 79.321

Review 8.  Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review.

Authors:  Daniel Pewsner; Peter Jüni; Matthias Egger; Markus Battaglia; Johan Sundström; Lucas M Bachmann
Journal:  BMJ       Date:  2007-08-28

9.  Dietary sodium alters the prevalence of electrocardiogram determined left ventricular hypertrophy in hypertension.

Authors:  Anand Vaidya; Rhonda Bentley-Lewis; Xavier Jeunemaitre; Gail K Adler; Jonathan S Williams
Journal:  Am J Hypertens       Date:  2009-03-05       Impact factor: 2.689

10.  Long term effects of dietary sodium reduction on cardiovascular disease outcomes: observational follow-up of the trials of hypertension prevention (TOHP).

Authors:  Nancy R Cook; Jeffrey A Cutler; Eva Obarzanek; Julie E Buring; Kathryn M Rexrode; Shiriki K Kumanyika; Lawrence J Appel; Paul K Whelton
Journal:  BMJ       Date:  2007-04-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.